Biologic drug survival rates in the era of anti-interleukin-17 antibodies: a time-period-adjusted registry analysis

T. Graier, W. Salmhofer, C Jonak, Wolfgang Weger, C. Kölli, B. Gruber, PG Sator, K. Prillinger, A. Mlynek, Martina Schütz-Bergmayr, L. Richter, Gudrun Ratzinger, C. Painsi, S. Selhofer, N. Häring, K. Wippel-Slupetzky, H. Skvara, H. Trattner, A. Tanew, A. InzingerR. Tatarski, C. Bangert, Christina Ellersdorfer, R. Lichem, A. Gruber-Wackernagel, Angelika Hofer, F. Legat, E. Schmiedberger, Robert Strohal, Bernhard Lange-Asschenfeldt, Matthias Schmuth, I. Vujic, Wolfram Hötzenecker, F. Trautinger, Werner Saxinger, Robert R. Müllegger, F. Quehenberger, P. Wolf

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)1094-1105
Number of pages12
JournalBritish Journal of Dermatology
Volume184
Issue number6
DOIs
Publication statusPublished - 2021

Fields of science

  • 302087 Venereology
  • 302011 Dermatology

Cite this